author-photo

Frederic Gilles

University of Texas MD Anderson Cancer Center

12

Papers

714

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Author reply [2]

2007 Cancer
Show All
- Source
- Cite
- Save
Citations (27)
The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma

2005 Cancer
Show All
- Source
- Cite
- Save
Citations (22)
Phase II Study of Proteasome Inhibitor Bortezomib in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

2005 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (494)
Sensitivity, Schedule-Dependence and Molecular Effects of the Proteasome Inhibitor Bortezomib in Non-Hodgkin’s Lymphoma Cells.

2004 Blood
Show All
- Source
- Cite
- Save
Citations (12)
Update on the Proteasome Inhibitor Bortezomibin Hematologic Malignancies

2004 Clinical Lymphoma, Myeloma & Leukemia
- Andre Goy
- Frederic Gilles
Show All
- Source
- Cite
- Save
Citations (31)
Prognostic value of soluble MUC1 and anti-MUC1 antibody levels in patients with diffuse large B-cell lymphoma.

2004 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Establishment and Characterization by Gene Expression Profiling of a New Diffuse Large B-Cell Lymphoma Cell Line, EJ-1, Carrying t(14;18) and t(8;14) Translocations

2003 Laboratory Investigation
Show All
- Source
- Cite
- Save
Citations (5)
Prognostic Significance of MUC-1 Expression in Systemic Anaplastic Large Cell Lymphoma

2003 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (22)
Establishment of a Human Cell Line (SKI-DLCL-1) with a t( 1;14)(q21;q32) Translocation from the Ascites of a Patient with Diffuse Large Cell Lymphoma

2001 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (14)